A significant increase in tumor CD8+ T lymphocytes, as detected by flow cytometry, was observed in the PDT-based DC vaccine group (vs. control group and LPS-treated DC vaccine group, termed DC vaccine here below) (Figure 5A and Figure S3A). This evidence concerns the gene CD8A and neoplasm.